We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$657M
AUM Growth
+$275M
Cap. Flow
+$250M
Cap. Flow %
38.11%
Top 10 Hldgs %
46.95%
Holding
2,266
New
348
Increased
793
Reduced
382
Closed
125

Sector Composition

Rank Sector Weight
1 Financials 14%
2 Technology 12.89%
3 Consumer Discretionary 4.89%
4 Healthcare 4.71%
5 Communication Services 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLM icon
1176
SLM Corp
SLM
$5.15B
$13K ﹤0.01%
677
+484
+251% +$8.87K
STE icon
1177
Steris
STE
$23.1B
$13K ﹤0.01%
54
+21
+64% +$4.8K
SWK icon
1178
Stanley Black & Decker
SWK
$15.7B
$13K ﹤0.01%
67
-12
-15% -$2.22K
TAN icon
1179
Invesco Solar ETF
TAN
$1.38B
$13K ﹤0.01%
163
+150
+1,154% +$13.1K
TTMI icon
1180
TTM Technologies
TTMI
$14.5B
$13K ﹤0.01%
900
UMBF icon
1181
UMB Financial
UMBF
$11.1B
$13K ﹤0.01%
122
VGK icon
1182
Vanguard FTSE Europe ETF
VGK
$31.1B
$13K ﹤0.01%
+185
New +$12.5K
VIPS icon
1183
Vipshop
VIPS
$7.53B
$13K ﹤0.01%
1,545
+747
+94% +$7.82K
WEX icon
1184
WEX
WEX
$6.31B
$13K ﹤0.01%
90
+82
+1,025% +$12.5K
NEX
1185
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$13K ﹤0.01%
3,548
+182
+5% +$762
ABEV icon
1186
Ambev
ABEV
$46.4B
$12K ﹤0.01%
4,193
+202
+5% +$579
ADAP
1187
DELISTED
Adaptimmune Therapeutics
ADAP
$12K ﹤0.01%
3,275
-5,392
-62% -$24.5K
APA icon
1188
APA Corp
APA
$13.2B
$12K ﹤0.01%
438
+30
+7% +$796
APO icon
1189
Apollo Global Management
APO
$73.4B
$12K ﹤0.01%
171
+2
+1% +$144
AVAL icon
1190
Grupo Aval
AVAL
$6.01B
$12K ﹤0.01%
2,276
-27
-1% -$151
AWR icon
1191
American States Water
AWR
$3.46B
$12K ﹤0.01%
119
-14
-11% -$1.32K
BALY icon
1192
Bally's
BALY
$658M
$12K ﹤0.01%
319
BBT
1193
Beacon Financial Corp
BBT
$2.66B
$12K ﹤0.01%
411
BBBY
1194
Bed Bath & Beyond
BBBY
$442M
$12K ﹤0.01%
220
CLLS
1195
Cellectis
CLLS
$285M
$12K ﹤0.01%
1,529
+1,066
+230% +$10.5K
CVAC
1196
DELISTED
CureVac
CVAC
$12K ﹤0.01%
+363
New +$14.6K
EDIT icon
1197
Editas Medicine
EDIT
$442M
$12K ﹤0.01%
467
+437
+1,457% +$15K
LKFT
1198
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$12K ﹤0.01%
213
+8
+4% +$417
GSBC icon
1199
Great Southern Bancorp
GSBC
$878M
$12K ﹤0.01%
202
IT icon
1200
Gartner
IT
$11.7B
$12K ﹤0.01%
36

Similar funds

Lindbrook Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Lindbrook Capital held 2,266 positions worth $657M, up 72% from $382M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Lindbrook Capital deployed $250M of net new capital in Q4 2021, opening 348 new positions and adding to 793 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 192,700 shares worth $10.9M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $1.92M trimmed.

  • Lindbrook Capital's largest Q4 2021 buy was iShares Core S&P Mid-Cap ETF: 192,700 shares worth $10.9M.
  • Lindbrook Capital added most to iShares Russell 1000 Growth ETF in Q4 2021, an estimated $29.7M increase.
  • Lindbrook Capital's biggest Q4 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $1.92M.
  • Lindbrook Capital fully exited iShares MSCI South Korea ETF in Q4 2021, selling an estimated $93K.
  • Lindbrook Capital's ten largest holdings make up 47% of its $657M portfolio in Q4 2021.
  • Lindbrook Capital opened 348 new positions and closed 125 in Q4 2021.
  • Lindbrook Capital's portfolio value rose 72% quarter-over-quarter to $657M.

Based on Lindbrook Capital's 13F filing for Q4 2021, filed 18 Jan 2022.